Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments

Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome

Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481 · see citing works

Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex

Nan, X., Ng, H.-H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., & Bird, A. (1998) · Nature · doi:10.1038/30764 · Cited by 3,440 · see citing works

Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription

Jones, P. L., Veenstra, G. J. C., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., Strouboulis, J., & Wolffe, A. P. (1998) · Nature Genetics · doi:10.1038/561 · Cited by 2,734 · see citing works

Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox

Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkert, A. J. M. H., Holden, J. J. A., Fenwick, R. G., Warren, S. T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90283-5 · Cited by 2,080 · see citing works

Absence of expression of the FMR-1 gene in fragile X syndrome

Pieretti, M., Zhang, F., Fu, Y.-H., Warren, S. T., Oostra, B. A., Caskey, C. T., & Nelson, D. L. (1991) · Cell · doi:10.1016/0092-8674(91)90125-i · Cited by 1,476 · see citing works

Cellular Memory and the Histone Code

Turner, B. M. (2002) · Cell · doi:10.1016/s0092-8674(02)01080-2 · Cited by 1,142 · see citing works

Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome

Brown, V., Jin, P., Ceman, S., Darnell, J. C., O'Donnell, W. T., Tenenbaum, S. A., Jin, X., Feng, Y., Wilkinson, K. D., Keene, J. D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00568-2 · Cited by 1,109 · see citing works

Heterochromatin and Epigenetic Control of Gene Expression

Grewal, S. I. S., & Moazed, D. (2003) · Science · doi:10.1126/science.1086887 · Cited by 1,065 · see citing works

Histone methylation in transcriptional control

Kouzarides, T. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00287-3 · Cited by 908 · see citing works

CpG methylation, chromatin structure and gene silencing—a three‐way connection

Razin, A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.4905 · Cited by 791 · see citing works

Elevated Levels of FMR1 mRNA in Carrier Males: A New Mechanism of Involvement in the Fragile-X Syndrome

Tassone, F., Hagerman, R. J., Taylor, A. K., Gane, L. W., Godfrey, T. E., & Hagerman, P. J. (2000) · The American Journal of Human Genetics · doi:10.1086/302720 · Cited by 775 · see citing works

An epigenetic road map for histone lysine methylation

Lachner, M., O’Sullivan, R. J., & Jenuwein, T. (2003) · Journal of Cell Science · doi:10.1242/jcs.00493 · Cited by 630 · see citing works

Maintenance of Stable Heterochromatin Domains by Dynamic HP1 Binding

Cheutin, T., McNairn, A. J., Jenuwein, T., Gilbert, D. M., Singh, P. B., & Misteli, T. (2003) · Science · doi:10.1126/science.1078572 · Cited by 616 · see citing works

Correlation Between Histone Lysine Methylation and Developmental Changes at the Chicken β-Globin Locus

Litt, M. D., Simpson, M., Gaszner, M., Allis, C. D., & Felsenfeld, G. (2001) · Science · doi:10.1126/science.1064413 · Cited by 579 · see citing works

Autosomal XX sex reversal caused by duplication ofSOX9

Huang, B., Wang, S., Ning, Y., Lamb, A. N., & Bartley, J. A. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19991203)87:4 · Cited by 424 · see citing works

Translational Suppression by Trinucleotide Repeat Expansion at <i>FMR1</i>

Feng, Y., Zhang, F., Lokey, L. K., Chastain, J. L., Lakkis, L., Eberhart, D., & Warren, S. T. (1995) · Science · doi:10.1126/science.7732383 · Cited by 358 · see citing works

Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells

Coffee, B., Zhang, F., Warren, S. T., & Reines, D. (1999) · Nature Genetics · doi:10.1038/8807 · Cited by 325 · see citing works

High functioning fragile X males: Demonstration of an unmethylated fully expanded FMR‐1 mutation associated with protein expression

Hagerman, R. J., Hull, C. E., Safanda, J. F., Carpenter, I., Staley, L. W., O'Connor, R. A., Seydel, C., Mazzocco, M. M. M., Snow, K., Thibodeau, S. N., et al. (1994) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320510404 · Cited by 222 · see citing works

Synergistic Effect of Histone Hyperacetylation and DNA Demethylation in the Reactivation of the FMR1 Gene

Chiurazzi, P., Grazia Pomponi, M., Pietrobono, R., Bakker, C. E., Neri, G., & Oostra, B. A. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.12.2317 · Cited by 217 · see citing works

Histone Modifications Depict an Aberrantly Heterochromatinized FMR1 Gene in Fragile X Syndrome

Coffee, B. W., Zhang, F. P., Ceman, S., Warren, S. T., & Reines, D. (2002) · The American Journal of Human Genetics · doi:10.1086/342931 · Cited by 200 · see citing works

In Vitro Reactivation of the FMR1 Gene Involved in Fragile X Syndrome

Chiurazzi, P., Pomponi, M. G., Willemsen, R., Oostra, B. A., & Neri, G. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.1.109 · Cited by 198 · see citing works

Normal phenotype in two brothers with a full FMR1 mutation

Smeets, H. J. M., Smits, A. P. T., Verheij, C. E., Theelen, J. P. G., Willemsen, R., Burgt, I. V. D., Hoogeveen, A. T., Oosterwijk, J. C., & Oostra, B. A. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.11.2103 · Cited by 179 · see citing works

Molecular dissection of the events leading to inactivation of the FMR1 gene

Pietrobono, R., Tabolacci, E., Zalfa, F., Zito, I., Terracciano, A., Moscato, U., Bagni, C., Oostra, B., Chiurazzi, P., & Neri, G. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi024 · Cited by 130 · see citing works

Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine

Pietrobono, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf434 · Cited by 118 · see citing works

Molecular Insights into Mental Retardation: Multiple Functions for the Fragile X Mental Retardation Protein?

Zalfa, F., & Bagni, C. (2004) · Current Issues in Molecular Biology · doi:10.21775/cimb.006.073 · Cited by 32 · see citing works

Butyrate and acetyl‐carnitine inhibit the cytogenetic expression of the fragile X in vitro

Pomponi, M. G., & Neri, G. (1994) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320510428 · Cited by 26 · see citing works

Modulation of methylation in the FMR1 promoter region after long term treatment with L-carnitine and acetyl-L-carnitine

Pascale, E., Battiloro, E., Reale, G. C., Pietrobono, R., Pomponi, M. G., Chiurazzi, P., Nicolai, R., Calvani, M., Neri, G., & D’Ambrosio, E. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.6.e76 · Cited by 18 · see citing works

Therapeutic application of histone deacetylase inhibitors for central nervous system disorders

Kazantsev, A. G., & Thompson, L. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2681 · Cited by 715 · see citing works

Therapeutic potential of mood stabilizers lithium and valproic acid:Beyond bipolar disorder

Chiu, C.-T., Wang, Z., Hunsberger, J. G., & Chuang, D.-M. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005512 · Cited by 404 · see citing works

Differential modeling of Fragile X syndrome by human embryonic stem cells and induced-pluripotent stem cells

Urbach, A., Bar-Nur, O., Daley, G., & Benvenisty, N. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.005 · Cited by 411 · see citing works

Epigenetic regulation of gene expression in physiological and pathological brain processes

Gräff, J., Kim, D., Dobbin, M. M., & Tsai, L.-H. (2011) · Physiological Reviews · doi:10.1152/physrev.00012.2010 · Cited by 373 · see citing works

Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics

Bagni, C., Tassone, F., Neri, G., & Hagerman, R. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63141 · Cited by 321 · see citing works

Epigenetic codes in cognition and behaviour

Gräff, J., & Mansuy, I. M. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.01.021 · Cited by 307 · see citing works

Developmental Study of Fragile X Syndrome Using Human Embryonic Stem Cells Derived from Preimplantation Genetically Diagnosed Embryos

Eiges, R., Urbach, A., Malcov, M., Frumkin, T., Schwartz, T., Amit, A., Yaron, Y., Eden, A., Yanuka, O., Benvenisty, N., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.09.001 · Cited by 287 · see citing works

The biological effects of simple tandem repeats: Lessons from the repeat expansion diseases: Table 1.Preprint

Usdin, K. (2008) · Genome Research · doi:10.1101/gr.070409.107 · Cited by 261 · see citing works

The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues

Al‐Mahdawi, S., Pinto, R. M., Ismail, O., Varshney, D., Lymperi, S., Sandi, C., Trabzuni, D., & Pook, M. A. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm346 · Cited by 254 · see citing works

An epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy

Millan, M. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.015 · Cited by 229 · see citing works

Epigenetic dysregulation in cognitive disorders

Gräff, J., & Mansuy, I. M. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06787.x · Cited by 163 · see citing works

Fragile X syndrome: An overview and update of the FMR1 gene

Milà, M., Álvarez‐Mora, M. I., Madrigal, I., & Rodríguez‐Revenga, L. (2017) · Clinical Genetics · doi:10.1111/cge.13075 · Cited by 136 · see citing works

The promise and perils of HDAC inhibitors in neurodegeneration

Didonna, A., & Opal, P. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.147 · Cited by 120 · see citing works

Of Men and Mice: Modeling the Fragile X Syndrome

Dahlhaus, R. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00041 · Cited by 118 · see citing works

Epigenetics, Autism Spectrum, and Neurodevelopmental Disorders

Rangasamy, S., D’Mello, S. R., & Narayanan, V. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0227-0 · Cited by 118 · see citing works

The FMR1 gene and fragile X‐associated tremor/ataxia syndrome

Brouwer, J. R., Willemsen, R., & Oostra, B. A. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30910 · Cited by 113 · see citing works

Histone Deacetylases Suppress CGG Repeat–Induced Neurodegeneration Via Transcriptional Silencing in Models of Fragile X Tremor Ataxia Syndrome

Todd, P. K., Oh, S. Y., Krans, A., Pandey, U. B., Prospero, N. A. D., Min, K., Taylor, J. P., & Paulson, H. L. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001240 · Cited by 99 · see citing works

A double‐blind, parallel, multicenter comparison of <scp>L</scp>‐acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys

Torrioli, M. G., Vernacotola, S., Peruzzi, L., Tabolacci, E., Mila, M., Militerni, R., Musumeci, S., Ramos, F. J., Frontera, M., Sorge, G., et al. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32268 · Cited by 100 · see citing works

Implication of abnormal epigenetic patterns for human diseases

Santos-Rebouças, C. B., & Pimentel, M. M. G. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201727 · Cited by 100 · see citing works

Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug development

Pop, A. S., Gomez‐Mancilla, B., Neri, G., Willemsen, R., & Gasparini, F. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3330-3 · Cited by 94 · see citing works

Epigenetic analysis reveals a euchromatic configuration in the FMR1 unmethylated full mutations

Tabolacci, E., Moscato, U., Zalfa, F., Bagni, C., Chiurazzi, P., & Neri, G. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.130 · Cited by 91 · see citing works

The distribution of repressive histone modifications on silenced FMR1 alleles provides clues to the mechanism of gene silencing in fragile X syndrome

Kumari, D., & Usdin, K. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq394 · Cited by 90 · see citing works

Human molecular genetics

Words, K., Genetics, H. M., Ismail, O., Varshney, D., Lymperi, S., Sandi, C., Trabzuni, D., & Pook, M. A. (1996) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)89770-1 · Cited by 88 · see citing works

SIRT1 Inhibition Alleviates Gene Silencing in Fragile X Mental Retardation Syndrome

Biacsi, R. E., Kumari, D., & Usdin, K. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000017 · Cited by 83 · see citing works

Epigenetics of fragile X syndrome and fragile X‐related disorders

Kraan, C. M., Godler, D. E., & Amor, D. J. (2018) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.13985 · Cited by 74 · see citing works

Treatment with valproic acid ameliorates ADHD symptoms in fragile X syndrome boys

Torrioli, M., Vernacotola, S., Setini, C., Bevilacqua, F., Martinelli, D., Snape, M., Hutchison, J. A., Di Raimo, F. R., Tabolacci, E., & Neri, G. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33484 · Cited by 71 · see citing works

Genetics and Epigenetics in Adult NeurogenesisPreprint

Hsieh, J., & Zhao, X. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a018911 · Cited by 71 · see citing works

FMR1 Epigenetic Silencing Commonly Occurs in Undifferentiated Fragile X-Affected Embryonic Stem Cells

Avitzour, M., Mor‐Shaked, H., Yanovsky‐Dagan, S., Aharoni, S., Altarescu, G., Renbaum, P., Eldar‐Geva, T., Schonberger, O., Levy‐Lahad, E., Epsztejn‐Litman, S., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.09.001 · Cited by 69 · see citing works

Population- and Family-Based Studies Associate the MTHFR Gene with Idiopathic Autism in Simplex Families

Liu, X., Solehdin, F., Cohen, I. L., Gonzalez, M. G., Jenkins, E. C., Lewis, M. E. S., & Holden, J. J. A. (2011) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-010-1120-x · Cited by 62 · see citing works

Epigenetic Characterization of the FMR1 Promoter in Induced Pluripotent Stem Cells from Human Fibroblasts Carrying an Unmethylated Full Mutation

de Esch, C. E. F., Ghazvini, M., Loos, F., Schelling-Kazaryan, N., Widagdo, W., Munshi, S. T., van der Wal, E., Douben, H., Gunhanlar, N., Kushner, S. A., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.07.013 · Cited by 58 · see citing works

The Neurobiology of X-Linked Intellectual Disability

Bassani, S., Zapata, J., Gerosa, L., Moretto, E., Murru, L., & Passafaro, M. (2013) · The Neuroscientist · doi:10.1177/1073858413493972 · Cited by 54 · see citing works

DNA Methylation, Mechanisms of FMR1 Inactivation and Therapeutic Perspectives for Fragile X Syndrome

Nobile, V., Pucci, C., Chiurazzi, P., Neri, G., & Tabolacci, E. (2021) · Biomolecules · doi:10.3390/biom11020296 · Cited by 50 · see citing works

The FRAXopathies: Definition, overview, and update

Pirozzi, F., Tabolacci, E., & Neri, G. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34113 · Cited by 46 · see citing works

Role of CTCF Protein in Regulating FMR1 Locus Transcription

Lanni, S., Goracci, M., Borrelli, L., Mancano, G., Chiurazzi, P., Moscato, U., Ferrè, F., Helmer‐Citterich, M., Tabolacci, E., & Neri, G. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003601 · Cited by 46 · see citing works

Emerging roles of epigenetic mechanisms in Parkinson’s disease

Habibi, E., Masoudi‐Nejad, A., Abdolmaleky, H. M., & Haggarty, S. J. (2011) · Functional & Integrative Genomics · doi:10.1007/s10142-011-0246-z · Cited by 46 · see citing works

Modest reactivation of the mutant FMR1 gene by valproic acid is accompanied by histone modifications but not DNA demethylation

Tabolacci, E., De Pascalis, I., Accadia, M., Terracciano, A., Moscato, U., Chiurazzi, P., & Neri, G. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32830500a1 · Cited by 44 · see citing works

Epigenetic modifications in trinucleotide repeat diseases

Evans‐Galea, M. V., Hannan, A. J., Carrodus, N. L., Delatycki, M. B., & Saffery, R. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.07.007 · Cited by 44 · see citing works

Epigenetics in Nucleotide Repeat Expansion Disorders

He, F., & Todd, P. K. (2011) · Seminars in Neurology · doi:10.1055/s-0031-1299786 · Cited by 42 · see citing works

DNA Methyltransferase Inhibitors: Development and Applications.

Lopez, M., Halby, L., & Arimondo, P. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-43624-1_16 · Cited by 25 · see citing works

Transcriptional Reactivation of the FMR1 Gene. A Possible Approach to the Treatment of the Fragile X Syndrome

Tabolacci, E., Palumbo, F., Nobile, V., & Neri, G. (2016) · Genes · doi:10.3390/genes7080049 · Cited by 37 · see citing works

Epigenetics, fragile X syndrome and transcriptional therapy

Tabolacci, E., & Chiurazzi, P. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36264 · Cited by 35 · see citing works

Incomplete silencing of full mutation alleles in males with fragile X syndrome is associated with autistic features

Baker, E. K., Arpone, M., Aliaga, S., Bretherton, L., Kraan, C. M., Bui, M., Slater, H. R., Ling, L., Francis, D. I., Hunter, M. F., et al. (2019) · Molecular Autism · doi:10.1186/s13229-019-0271-7 · Cited by 35 · see citing works

Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Tabolacci, E., Mancano, G., Lanni, S., Palumbo, F., Goracci, M., Ferrè, F., Helmer‐Citterich, M., & Neri, G. (2016) · Epigenetics & Chromatin · doi:10.1186/s13072-016-0060-x · Cited by 33 · see citing works

The FMR1 promoter is selectively hydroxymethylated in primary neurons of fragile X syndrome patients

Esanov, R., Andrade, N. S., Bennison, S. A., Wahlestedt, C., & Zeier, Z. R. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw311 · Cited by 32 · see citing works

Inhibitors of DNA Methylation

Lopez, M., Gilbert, J., Contreras, J., Halby, L., & Arimondo, P. B. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-11454-0_17 · Cited by 31 · see citing works

Bidirectional transcription of trinucleotide repeats: Roles for excision repair

Budworth, H., & McMurray, C. T. (2013) · DNA repair · doi:10.1016/j.dnarep.2013.04.019 · Cited by 33 · see citing works

Reversible histone methylation regulates brain gene expression and behavior

Xu, J., & Andreassi, M. (2010) · Hormones and Behavior · doi:10.1016/j.yhbeh.2010.08.019 · Cited by 30 · see citing works

Reevaluation of FMR1 Hypermethylation Timing in Fragile X Syndrome

Mor‐Shaked, H., & Eiges, R. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00031 · Cited by 27 · see citing works

Valproate protective effects on cisplatin-induced peripheral neuropathy: an in vitro and in vivo study.

Rodriguez‐Menendez, V., Gilardini, A., Bossi, M., Canta, A., Oggioni, N., Carozzi, V., Tremolizzo, L., & Cavaletti, G. (2008) · PubMed · Cited by 24 · see citing works

Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome

Brasa, S., Mueller, A., Jacquemont, S., Hahne, F., Rozenberg, I., Peters, T., He, Y., McCormack, C., Gasparini, F., Chibout, S., et al. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0181-x · Cited by 24 · see citing works

Modeling Fragile X Syndrome Using Human Pluripotent Stem Cells

Mor‐Shaked, H., & Eiges, R. (2016) · Genes · doi:10.3390/genes7100077 · Cited by 20 · see citing works

Where Environment Meets Cognition: A Focus on Two Developmental Intellectual Disability Disorders

Toma, I. D., Manubens-Gil, L., Ossowski, S., & Dierssen, M. (2016) · Neural Plasticity · doi:10.1155/2016/4235898 · Cited by 19 · see citing works

Acetylcarnitine potentiates the anticarcinogenic effects of butyrate on SW480 colon cancer cells

Elimrani, I., Dionne, S., Saragosti, D., Qureshi, I. A., Levy, E. H., Delvin, E., & Seidman, E. G. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3029 · Cited by 18 · see citing works

Epigenetic Aberration of FMR1 Gene in Infertile Women with Diminished Ovarian Reserve.

Eslami, H., Eslami, A., Favaedi, R., Asadpour, U., Moradi, S. Z., Eftekhari‐Yazdi, P., Madani, T., Shahhoseini, M., & Meybodi, A. M. (2018) · PubMed Central · doi:10.22074/cellj.2018.4398 · Cited by 16 · see citing works

Genetic and Epigenetic Interplay Define Disease Onset and Severity in Repeat Diseases

Barbé, L., & Finkbeiner, S. M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.750629 · Cited by 14 · see citing works

Inhibition of histone deacetylases in rats self‐administering cocaine regulates lissencephaly gene‐1 and reelin gene expression, as revealed by microarray technique

Host, L., Anglard, P., Romieu, P., Thibault-Carpentier, C., Dembélé, D., Aunis, D., & Zwiller, J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06591.x · Cited by 15 · see citing works

Epigenetic Research in Stem Cell Bioengineering—Anti-Cancer Therapy, Regenerative and Reconstructive Medicine in Human Clinical Trials

Dompé, C., Janowicz, K., Hutchings, G., Moncrieff, L., Jankowski, M., Nawrocki, M. J., Józkowiak, M., Mozdziak, P. E., Petitte, J. N., Shibli, J. A., et al. (2020) · Cancers · doi:10.3390/cancers12041016 · Cited by 14 · see citing works

FMR1 CGG repeat lengths mediate different regulation of reporter gene expression in comparative transient and locus specific integration assays

Sølvsten, C. A. E., & Nielsen, A. L. (2011) · Gene · doi:10.1016/j.gene.2011.06.034 · Cited by 12 · see citing works

Improved Methodology for Assessment of mRNA Levels in Blood of Patients with FMR1 Related Disorders

Godler, D. E., Loesch, D. Z., Huggins, R., Gordon, L., Slater, H. R., Gehling, F., Burgess, T., & Choo, K. A. (2009) · BMC Clinical Pathology · doi:10.1186/1472-6890-9-5 · Cited by 12 · see citing works

Mecanismos epigenéticos en el desarrollo de la memoria y su implicación en algunas enfermedades neurológicas

Reynoso, M. A. R., Ochoa-Hernández, A. B., Juárez-Vázquez, C. I., & Barros‐Núñez, P. (2014) · Neurología · doi:10.1016/j.nrl.2014.02.004 · Cited by 12 · see citing works

Mitochondrial dysfunction in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome: prospect use of antioxidants and mitochondrial nutrients

Pagano, G., Lyakhovich, A., Pallardó, F. V., Tiano, L., Zatterale, A., & Trifuoggi, M. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09415-7 · Cited by 10 · see citing works

DNA Methylation and Trinucleotide Repeat Expansion Diseases

Mark, A. (2012) · InTech eBooks · doi:10.5772/34169 · Cited by 11 · see citing works

The Contribution of Pluripotent Stem Cell (PSC)-Based Models to the Study of Fragile X Syndrome (FXS)

Diab, M. A., & Eiges, R. (2019) · Brain Sciences · doi:10.3390/brainsci9020042 · Cited by 10 · see citing works

Defining the role of the CGGBP1 protein in FMR1 gene expression

Goracci, M., Lanni, S., Mancano, G., Palumbo, F., Chiurazzi, P., Neri, G., & Tabolacci, E. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.182 · Cited by 9 · see citing works

Epigenetic mechanisms in the development of memory and their involvement in certain neurological diseases

Reynoso, M. A. R., Ochoa-Hernández, A. B., Juárez-Vázquez, C. I., & Barros‐Núñez, P. (2016) · Neurología (English Edition) · doi:10.1016/j.nrleng.2014.02.011 · Cited by 9 · see citing works

Novel Therapeutic Targets in Neuropsychiatric Disorders: The Neuroepigenome

Tremolizzo, L., Rodriguez‐Menendez, V., Conti, E., Zoia, C., Cavaletti, G., & Ferrarese, C. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990535 · Cited by 7 · see citing works

L-acetylcarnitine for treating fragile X syndrome

Rueda, J.-R., Guillén, V., Ballesteros, J., Tejada, M., & Solà, I. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010012.pub2 · Cited by 6 · see citing works

DNA methylation: dynamic and stable regulation of memory

Vaissière, T., & Miller, C. A. (2011) · BioMolecular Concepts · doi:10.1515/bmc.2011.046 · Cited by 6 · see citing works

Epigenetic Modifications of the FMR1 Gene

Tabolacci, E., & Neri, G. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-411-1_10 · Cited by 5 · see citing works

Trinucleotide repeat expansion and RNA dysregulation in fragile X syndrome: emerging therapeutic approaches

Jung, S., & Richter, J. D. (2024) · RNA · doi:10.1261/rna.080270.124 · Cited by 2 · see citing works

Epigenetics and Epigenomics in Human Health and Disease

Festenstein, R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-420196-5.00005-8 · Cited by 2 · see citing works

Monitoring for Epigenetic Modifications at the FMR1 Locus

Epsztejn‐Litman, S., & Eiges, R. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9080-1_3 · Cited by 2 · see citing works

Epigenetics and Pervasive Developmental Disorders

Gropman, A. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-417114-5.00019-x · Cited by 2 · see citing works

EZH2 inhibition reactivates epigenetically silenced FMR1 and normalizes molecular and electrophysiological abnormalities in fragile X syndrome neurons

Fang, M., Deibler, S. K., Krishnamurthy, P. M., Wang, F., Rodríguez, P. M., Banday, S., Virbasius, C.-M. A., Sena‐Esteves, M., Watts, J. K., & Green, M. R. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1348478 · Cited by 1 · see citing works

Epigenetic causes of intellectual disability—the fragile X syndrome paradigm

Tabolacci, E., & Neri, G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800226-1.00006-x · Cited by 1 · see citing works

Fragile X Syndrome in a Colombian Family

del Valle, U., Saldarriaga, W., Hagerman, R. J., Salcedo‐Arellano, M. J., del Valle, U., Tassone, F., Ramírez‐Cheyne, J., de Valle, U., Silva, M., & States, U. (2018) · IATREIA · doi:10.17533/udea.iatreia.v31n1a07 · Cited by 1 · see citing works

Epigenetics and pervasive developmental disorders

Gropman, A. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823577-5.00011-8 · Cited by 1 · see citing works

Epigenetic causes of intellectual disability—the fragile X syndrome paradigm

Tabolacci, E., & Neri, G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18516-8.00007-7 · Cited by 1 · see citing works

Brain in a Dish

Trujillo, C. A., Negraes, P. D., Hrvoj-Mihić, B., Lins, M. F. C., Semendeferi, K., & Muotri, A. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800105-9.00008-1 · Cited by 1 · see citing works

L-acetylcarnitine for fragile X syndrome

Rueda, J.-R., Guillén, V., Ballesteros, J., Tejada, M., & Solà, I. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010012 · Cited by 1 · see citing works

State of hypophsis-adrenal gland in conditions of vibration pathology and its correction in experiment.

Kapanadze, N. (2006) · PubMed

Mechanizmy epigenetyczne w chorobach psychicznych i zaburzeniach funkcji poznawczych Epigenetic mechanisms in psychiatric disorders and cognitive functions

Dmitrzak‐Węglarz, M., & Hauser, J. (2009)

Quantitative investigations of FXN transcription and epigenetic modifications, including histone acetylation and methylation, in FRDA human and mouse tissues.

Trabzuni, D. (2009) · Brunel University Research Archive (BURA) (Brunel University London)

What Mechanisms Induce Methylation of FMR1 Gene Full Mutation? A Still Unanswered Question

Tabolacci, E., & Neri, G. (2016) · Epigenetics and human health · doi:10.1007/978-3-319-27186-6_8

Reactivation of the FMR1 Gene

Tabolacci, E., & Chiurazzi, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804461-2.00017-2

Pharmacoepigenetics of Autism Spectrum Disorder

Hamza, M., Halayem, S., Mrad, R., & Belhadj, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813939-4.00024-3

The Emerging field of epigenetic editing: implication for translational purposes for diseases with developmental origin

Wang, M., & Liu, X. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821785-6.00002-5

Pharmacoepigenetics of autism spectrum disorder

Hamza, M., Halayem, S., Mrad, R., & Belhadj, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-18722-3.00017-7

Short tandem repeats and tandem repeat disorders

Ma, R., Liu, T., & Zhu, B. (2025) · Scientia Sinica Vitae · doi:10.1360/ssv-2025-0129

Non-CGG trinucleotide repeat expansions as pathogenic genetic mutations in Fragile X SyndromePreprint

da Cruz, A. C. P., Ferrasa, A., Masson, I. D. N., de Souza, J. S., Rodrigues, K. S., & Herai, R. H. (2025) · medRxiv · doi:10.1101/2025.10.22.25338597

Read-me : à la rencontre des protéines reconnaissant la méthylation de l'ADN avec des sondes chimiques. Synthèse et criblage

Contreras, J. (2024) · theses.fr (ABES) · doi:10.70675/6e0d75a7zab53z4381zb623za1392611526a

Perinatal arsenic exposure inhibits binding ability of glucocorticoid receptors to nuclear response elements altering gene expression and affecting learning behavior

Martinez‐Finley, E. J. (2010) · UNM’s Digital Repository (University of New Mexico)

Am. J. Hum. Genet. 71:923–932, 2002 Histone Modifications Depict an Aberrantly Heterochromatinized FMR1 Gene in Fragile X Syndrome

Coffee, B. W., Zhang, F., Ceman, S., Warren, S. T., & Reines, D. (2013)

Histone Modifications Depict an Aberrantly Heterochromatinized FMR1 Gene in Fragile X Syndrome

Coffee, B. W., Zhang, F. P., Ceman, S., Warren, S. T., & Reines, D. (2002) · The American Journal of Human Genetics · doi:10.1086/342931 · Cited by 200 · see citing works

Synergistic Effect of Histone Hyperacetylation and DNA Demethylation in the Reactivation of the FMR1 Gene

Chiurazzi, P., Grazia Pomponi, M., Pietrobono, R., Bakker, C. E., Neri, G., & Oostra, B. A. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.12.2317 · Cited by 217 · see citing works

Small Molecules Targeting H3K9 Methylation Prevent Silencing of Reactivated FMR1 Alleles in Fragile X Syndrome Patient Derived Cells

Kumari, D., Sciascia, N., & Usdin, K. (2020) · Genes · doi:10.3390/genes11040356 · Cited by 25 · see citing works

Modest reactivation of the mutant FMR1 gene by valproic acid is accompanied by histone modifications but not DNA demethylation

Tabolacci, E., De Pascalis, I., Accadia, M., Terracciano, A., Moscato, U., Chiurazzi, P., & Neri, G. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32830500a1 · Cited by 44 · see citing works